CORT Price / Book | CORCEPT THERAPEUTICS INC

CORCEPT THERAPEUTICS INC Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

CORCEPT THERAPEUTICS INC price/book ratio for the quarter ending 2026-06-30 was 13.22, a 7.96% increase year-over-year.
CORCEPT THERAPEUTICS INC price/book ratio for the quarter ending 2026-03-31 was 6.72, a 61.90% decline year-over-year.
CORCEPT THERAPEUTICS INC price/book ratio for the quarter ending 2025-12-31 was 5.69, a 26.98% decline year-over-year.
CORCEPT THERAPEUTICS INC price/book ratio for the quarter ending 2025-09-30 was 13.86, a 83.10% increase year-over-year.
CORCEPT THERAPEUTICS INC price/book ratio for fiscal 2026 was 13.22.
CORCEPT THERAPEUTICS INC price/book ratio for fiscal 2025 was 5.69, a 26.98% decline from fiscal 2024.
CORCEPT THERAPEUTICS INC price/book ratio for fiscal 2024 was 7.79, a 17.59% increase from fiscal 2023.
CORCEPT THERAPEUTICS INC price/book ratio for fiscal 2023 was 6.63, a 51.88% increase from fiscal 2022.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	13.22	$9.33B	$705.78M
2026-03-31	6.72	$4.29B	$637.99M
2025-12-31	5.69	$3.69B	$647.81M
2025-09-30	13.86	$8.76B	$631.9M
2025-06-30	12.25	$7.79B	$635.79M
2025-03-31	17.64	$12.05B	$683.29M
2024-12-31	7.79	$5.3B	$679.59M
2024-09-30	7.57	$4.84B	$638.84M
2024-06-30	5.67	$3.38B	$596.24M
2024-03-31	4.76	$2.61B	$547.86M
2023-12-31	6.63	$3.36B	$506.71M
2023-09-30	6.05	$2.79B	$461.68M
2023-06-30	5.36	$2.26B	$421.61M
2023-03-31	4.41	$2.34B	$529.58M
2022-12-31	4.36	$2.19B	$501.84M
2022-09-30	5.8	$2.75B	$473.36M
2022-06-30	5.71	$2.53B	$442.33M
2022-03-31	5.85	$2.39B	$407.81M
2021-12-31	5.58	$2.1B	$375.81M
2021-09-30	4.22	$2.28B	$540.23M
2021-06-30	4.91	$2.57B	$522.68M
2021-03-31	5.46	$2.79B	$510.8M
2020-12-31	5.84	$3.05B	$523.34M
2020-09-30	4.11	$2.01B	$489.68M
2020-06-30	4.25	$1.93B	$453.7M
2020-03-31	3.33	$1.36B	$409.49M
2019-12-31	3.73	$1.39B	$371.18M
2019-09-30	4.81	$1.61B	$334.38M
2019-06-30	4.3	$1.28B	$298.05M
2019-03-31	4.71	$1.35B	$285.76M
2018-12-31	5.57	$1.54B	$275.88M
2018-09-30	6.27	$1.63B	$259.55M
2018-06-30	7.44	$1.81B	$243.51M
2018-03-31	8.78	$1.89B	$215.23M
2017-12-31	10.85	$2.07B	$190.97M
2017-09-30	25.51	$2.2B	$86.3M
2017-06-30	20.22	$1.34B	$66.15M
2017-03-31	25	$1.24B	$49.58M
2016-12-31	19.78	$818.27M	$41.38M
2016-09-30	23.07	$720.73M	$31.25M
2016-06-30	23.51	$603.23M	$25.66M
2016-03-31	25.45	$513.26M	$20.17M
2015-12-31	29.52	$546.02M	$18.5M
2015-09-30	30.34	$408.88M	$13.48M
2015-06-30	56.43	$650.46M	$11.53M
2015-03-31	57.06	$603.24M	$10.57M
2014-12-31	-89.78	$304.19M	-$3.39M
2014-09-30	-205.81	$271.06M	-$1.32M
2014-06-30	82.02	$283.14M	$3.45M
2014-03-31	46.85	$439M	$9.37M
2013-12-31	15.25	$320.52M	$21.02M
2013-09-30	5.16	$158.7M	$30.77M
2013-06-30	4.28	$172.68M	$40.37M
2013-03-31	3.91	$199.63M	$51M
2012-12-31	2.31	$142.73M	$61.78M
2012-09-30	3.88	$278.11M	$71.65M
2012-06-30	12.13	$397.89M	$32.8M
2012-03-31	8.43	$331.51M	$39.32M
2011-12-31	8.28	$288.07M	$34.81M
2011-09-30	5.98	$261.03M	$43.67M
2010-12-31	13.16	$279.48M	$21.24M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	13.22	$9.33B	$705.78M
2025-12-31	5.69	$3.69B	$647.81M
2024-12-31	7.79	$5.3B	$679.59M
2023-12-31	6.63	$3.36B	$506.71M
2022-12-31	4.36	$2.19B	$501.84M
2021-12-31	5.58	$2.1B	$375.81M
2020-12-31	5.84	$3.05B	$523.34M
2019-12-31	3.73	$1.39B	$371.18M
2018-12-31	5.57	$1.54B	$275.88M
2017-12-31	10.85	$2.07B	$190.97M
2016-12-31	19.78	$818.27M	$41.38M
2015-12-31	29.52	$546.02M	$18.5M
2014-12-31	-89.78	$304.19M	-$3.39M
2013-12-31	15.25	$320.52M	$21.02M
2012-12-31	2.31	$142.73M	$61.78M
2011-12-31	8.28	$288.07M	$34.81M
2010-12-31	13.16	$279.48M	$21.24M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
BIOMARIN PHARMACEUTICAL INC (BMRN)	United States	$11.879B	151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
Jazz Pharmaceuticals plc (JAZZ)		$15.333B	16.07
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52